March 30, 2025

Renowned neurologist and UCLA researcher Dr. Rhonda Voskuhl was recently featured on ABC7 Los Angeles in connection with Oprah Winfrey’s national ABC special, “The Menopause Revolution.” The segment highlighted Dr. Voskuhl’s clinical insights into menopause-related cognitive decline and underscored CleopatraRX™’s pioneering approach to estrogen-based therapy designed to protect the brain.

Dr. Voskuhl emphasized that the cognitive changes women experience during menopause are real, measurable, and critically treatable.

“Not remembering why you walked into the room, losing verbal memory, not being able to maintain train of thought. These are domain-specific problems that interfere with their job, their confidence,” she explained during the ABC7 interview.

Highlighting CleopatraRX’s core innovation, Voskuhl explained how PearlPAK® uses a neuro-targeted form of estrogen to not just slow cognitive decline, but improve it.

“Taking it a year, we showed statistically significant improvement in cognition. Again, not just a slowing of decline, but actually an improvement,” she said.

With more women living well into their 80s, the health implications of menopause are more relevant than ever.

“Women are living longer, so it’s likely they may be in menopause for a third of their lives,” Voskuhl noted.

ABC7’s feature reinforces what CleopatraRX has championed for years: that menopause is not just a moment, but a long-term neurological transition one that deserves smarter, safer solutions.

Watch the full ABC7 segment here:

https://abc7.com/post/oprahs-menopause-revolution-challenges-silence-offers-new-solutions/16099383/